retatrutide and ghk cu American Peptides — Research-Grade Peptides — Third-Party Tested GHK-Cu Peptides Before and After:

doi: 10.1016/j.arbres.2025.02.014, 29

Unlike single-receptor agonists or dual agonists, this triagonist approach appears to produce synergistic effects on weight loss, glycemic control, and metabolic parameters through complementary pathway activation

Retatrutide's triple agonism shows promise for greater weight loss and liver fat reduction, but remains investigational with Phase 2 data only

This is an important treatment aspect, as weight reduction most likely plays an important role in the prevention and reduced progression of CKD, an association demonstrated in people with macroalbuminuria having undergone bariatric surgery [115]